Zoetis Profit Margin 2011-2021 | ZTS

Current and historical gross margin, operating margin and net profit margin for Zoetis (ZTS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Zoetis net profit margin as of June 30, 2021 is 25.76%.
Zoetis Annual Profit Margins
Zoetis Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $95.429B $6.675B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $53.797B 8.72
Catalent (CTLT) United States $23.434B 49.53
Taro Pharmaceutical Industries (TARO) Israel $2.364B 15.82
USANA Health Sciences (USNA) United States $1.769B 13.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.519B 7.64
Rafael Holdings (RFL) United States $0.646B 0.00
Lannett Co Inc (LCI) United States $0.130B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00